{
    "organizations": [],
    "uuid": "09b0a00916ac03df1cc92fea6dce0846074d2329",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-protalix-biotherapeutics-announces/brief-protalix-biotherapeutics-announces-final-dosing-of-last-patient-in-phase-ii-clinical-trial-of-oprx-106-idUSASB0C5X5",
    "ord_in_thread": 0,
    "title": "Protalix Biotherapeutics Announces Final Dosing Of Last Patient In Phase II Clinical Trial Of OPRX-106",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "  Updated 5 minutes ago BRIEF-Protalix Biotherapeutics Announces Final Dosing Of Last Patient In Phase II Clinical Trial Of OPRX-106 Reuters Staff 1 Min Read Feb 15 (Reuters) - Protalix Biotherapeutics Inc: * PROTALIX BIOTHERAPEUTICS ANNOUNCES FINAL DOSING OF LAST PATIENT IN PHASE II CLINICAL TRIAL OF OPRX-106 IN PATIENTS WITH ULCERATIVE COLITIS * PROTALIX BIOTHERAPEUTICS INC - EXPECTS TO REPORT TOP-LINE RESULTS FROM PHASE II CLINICAL STUDY OF OPRX-106 BY END OF MARCH 2018  ",
    "published": "2018-02-15T20:13:00.000+02:00",
    "crawled": "2018-02-15T14:21:45.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "biotherapeutics",
        "announces",
        "final",
        "dosing",
        "last",
        "patient",
        "phase",
        "ii",
        "clinical",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "protalix",
        "biotherapeutics",
        "inc",
        "protalix",
        "biotherapeutics",
        "announces",
        "final",
        "dosing",
        "last",
        "patient",
        "phase",
        "ii",
        "clinical",
        "trial",
        "patient",
        "ulcerative",
        "colitis",
        "protalix",
        "biotherapeutics",
        "inc",
        "expects",
        "report",
        "result",
        "phase",
        "ii",
        "clinical",
        "study",
        "end",
        "march"
    ]
}